MedPath

TRIAL FOR EVALUATING THE EFFICACY OF A NEW LEADLESS DEFIBRILLATOR SYSTEM

Not yet recruiting
Conditions
Pulmonary heart disease, unspecified,
Registration Number
CTRI/2022/04/042267
Lead Sponsor
CALYAN CARDIAC THERAPEUTICS INDIA PVT LTD
Brief Summary

This is A prospective, multi-site, single-arm, open-label feasibility study. This study is designed to evaluate the efficacy implant procedure and placement of the Calyan leadless defibrillator, and to evaluate the feasibility of defibrillation.Subjects Scheduled for ICD implantation will be recruited in the study.The device will be connected to anexternal defibrillator or ICD pulse generator, and defibrillation testing (ventricularfibrillation induction and cardioversion) will be performed.



The data from this study will be used to refine the device design, and to justify further investigation of the leadless defibrillation system.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
5
Inclusion Criteria
  • Female or male 2.
  • Age 18 or above 3.
  • Willing and capable of providing informed consent 4.
  • Scheduled for ICD implantation.
Exclusion Criteria
  • Patients with have previously undergone an open heart surgical procedure 2.
  • Currently implanted with a cardiac pacemaker, implantable cardioverter defibrillator, cardiac resynchronization, or neurostimulation device.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
defibrillation of the ventricle with the leadless defibrillation system.VISIT 2
Efficacy endpoint will be the number of patients with successfulVISIT 2
Secondary Outcome Measures
NameTimeMethod
Secconary endpoint will be the number of patients with successfuldefibrillation of the ventricle with the leadless defibrillation system.

Trial Locations

Locations (1)

Metromed International Cardiac Centre

🇮🇳

Kozhikode, KERALA, India

Metromed International Cardiac Centre
🇮🇳Kozhikode, KERALA, India
Prof Dr V Nandakumar
Principal investigator
8592851444
prof.nandakumarv@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.